Bharat Biotech Limited
Bharat biotech limited, Latest News
Bharat Biotech International Limited is an Indian biotechnology company headquartered in Hyderabad, India engaged in thedrug discovery, drug development, manufacture of vaccines, bio-therapeutics, pharmaceuticals and health care products.
Initial hiccups in Bharat Biotech Banglaore plant delayed Covaxin production: NTAGI Chief
India achieved the target of 47 crore COVID-19 vaccine doses till the month of July, Dr N K Arora, Chief of National Immunization Technical Advisory Group (NTAGI) said and added that some hiccups like initial difficulties in the new Bangalore plant o ...
Bharat Biotech's Rotavac 5D receives WHO prequalification
Hyderabad, Aug 2 Bharat Biotech on Monday announced that the World Health Organisation (WHO) has awarded prequalification to ... ...
Covaxin is effective against Delta Plus variant of Covid-19, says study
Bharat Biotech's COVID-19 vaccine Covaxin has shown less reduction in 'neutralizing activity' while comparing with Delta and Delta AY.1 (Delta plus) variants in those who are fully vaccinated with the vaccine according to a study by the Indian Counci ...
VP seeks expediting development of Covid vaccine for children
Hyderabad, July 30 Vice President, M. Venkaiah Naidu on Friday urged the scientific fraternity to focus on expediting ... ...
Vice President visits Bharat Biotech's facility in Hyderabad
Vice President M Venkaiah Naidu on Friday visited pharma major Bharat Biotech's COVID-19 vaccine manufacturing facility in Hyderabad. ...
COVID-19 vaccine manufacturing firms being encouraged to conduct paediatrics study, says Dr VK Paul
After trials on adults, COVID-19 vaccine manufacturing companies Biological E and Novavax are being encouraged to conduct a study on paediatrics, said Member-Health of NITI Aayog Dr VK Paul on Tuesday. ...
COVAXIN trial results on children likely by September: AIIMS chief Dr Randeep Guleria
Trials for Bharat Biotech's Covid-19 vaccine Covaxin on children are underway and results are expected to be released by September, All India Institute of Medical Sciences (AIIMS) director Randeep Guleria informed. ...
Bharat Biotech cancels contracts with 2 Brazil firms for Covaxin
Bharat Biotech on Friday said it has terminated agreements it had signed with two Brazilian companies - Precisa Medicamentos and Envixia Pharmaceuticals LLC to introduce its Covid-19 Covaxin in Brazil. ...
COVID-19: Second dose trial of Covaxin on 2-6 years to begin by next week
As part of its COVID-19 vaccination trials for children, Bharat Biotech is likely to administer the second dose of Covaxin to children aged between 2 and 6 years next week, sources said on Thursday. ...
Zydus Cadila expected to provide additional data on Covid-19 vaccine to DCGI this week
Emergency approval for Zydus Cadila's Covid-19 vaccine may take a few more days with the Ahmedabad-based pharma company set to submit additional data related to immunogenicity and safety of its Zycov-D vaccine to the Drugs Controller General of India ...